Diagnosis and treatment of metastatic and castration resistant prostate cancer became more and more and complex due to the increasing knowledge and understanding of the underlying molecular events and the subsequently deducted innovative medical treatment
Modern imaging studies in CRPCA have become more and more complex and selective and currently include positron emission tomography, whole body magnetic resonance imaging, immunoscintigraphy besides the traditional studies such as bone scans and computed tomography.
Observations From Early Adoption of Radium 223 (Ra-223) in Heavily Pretreated Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) International Journal of Radiation Oncology*Biology*Physics, Issue 1, Volume 90, page S440
About the Editors
Kurt Miller MD, PhD
Professor Miller has been Chairman and Professor of Urology for the Department of Urology at the Benjamin Franklin Medical Center, Berlin, Germany, since 1993. In 2007 he became Chairman of the ...
Read more »
Axel Merseburger MD, PhD
Prof Axel S. Merseburger is currently Vice Chairman of the Department of Urologic Oncology, as well as Director of the Urologic Oncology Programme at Hannover Medical School, Germany. ...
Read more »
28 November - 30 November
15th Course of the International School of Urology and Nephrology on Kidney Cancer: Innovation in Surgery and Oncology
Italy, EriceContact: Mrs. Serenella La Cavera Tel.: +39 0916251719 Fax: + 39 0916251719 E-mail: email@example.com Website: www.edipocongressi.it
5 December - 9 December
12th Asian Congress of Urology (ACU)
Kish Island, Iran
Contact: Urological Association of Asia and Iranian
Tel.: +6563214693 / Tel: +982188526902
Fax: +6562273787 / Fax: +982122657885
10 December - 13 December
Experts in Stone Disease (ESD)
Caep Town, South Africa
Contact: Erasmus S.A.
Tel.: +30 210 7414718
Fax: +30 210 7257532